PubMed Health⌕ Search

Biomedical subjects

Chi C Gu

Publications and source records attributed to Chi C Gu.

2 recordsLinked to original sources

Designing an optimum genetic association study using dense SNP markers and family-based sample.

Genetic association analysis using thousands of single nucleotide polymorphism (SNP) markers has become a promising alternative to genome-wide linkage scan. Analysis based on linkage-disequilibrium (LD) is more efficient because meiotic information of past generations is utilized. However, in addition to the physical distance between the disease locus and a marker locus, numerous other factors such as admixture, genetic drift, and multiple mutations can affect the observed value of LD. The effect of these factors in a genomic LD association study must be carefully analyzed to obtain an efficient study design. In the following review, we consider studies using family-based data and carefully study the effects of some of these important design factors, including the sample size, frequency of SNP markers, and marker density. For example, we conclude that (1) for reasonably frequent SNP markers, a moderately large sample of 500 families is appropriate for a moderately stringent significance level (alpha = 0.00009); (2) to maintain a power of 80%, maximal difference in allele frequencies between the disease gene and a SNP marker varies between 0.1 (under additive model) and 0.5 (multiplicative); (3) a map density of 10 cM is appropriate only under idea scenario (moderately large sample size, equal trait/marker allele frequencies, maximum LD strength etc.). Results shown here should have practical implications to designing efficient LD association studies using dense SNP markers.

Epidemiologic Research Design↗

Role of gene expression microarray analysis in finding complex disease genes.

The promise of gene expression studies using microarray technology has inspired much new hope for finding complex diseases genes. It has become clear that complex diseases result from collective actions of many genetic and nongenetic factors. Therefore, genetic dissection of complex diseases should be carried out in a global context. The technology of gene expression microarray analysis (GEMA) can provide such global information on transcription activities of essentially all genes simultaneously. It is hoped that this promising technology can be applied to samples drawn from large-scale, well-defined genetic epidemiological studies and help us untangle the web of pathways leading to complex diseases. However, extremely noisy GEMA data pose serious challenges in terms of the statistical methodologies needed. Extensive work is needed in order to respond to the challenges before one can fully utilize the potential power provided by GEMA. We begin in this paper by identifying several statistical problems related to the application of GEMA to genetic epidemiological analysis, and consider study designs that might benefit from this promising new technology. While it is still too early to tell how much of the enormous potential of GEMA will be realized ultimately, its success will probably depend most critically on the ability of statistical genetics to rise to the challenge of mining information from a sea of noise.

Gene Expression↗